Cargando…

Long‐term safety and tolerability of lacosamide monotherapy in patients with epilepsy: Results from a multicenter, open‐label trial

The primary objective of this trial (SP1042; NCT02582866) was to assess long‐term safety and tolerability of lacosamide monotherapy (200‐600 mg/day) in adults with focal (partial‐onset) seizures or generalized tonic‐clonic seizures (without clear focal origin). This Phase III, long‐term, open‐label,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ben‐Menachem, Elinor, Dominguez, Jacqueline, Szász, József, Beller, Cynthia, Howerton, Charles, Jensen, Lori, McClung, Carrie, Roebling, Robert, Steiniger‐Brach, Björn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Short Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408586/ https://www.ncbi.nlm.nih.gov/pubmed/34265173 http://dx.doi.org/10.1002/epi4.12522

Ejemplares similares

Long‐term safety and efficacy of lacosamide and controlled‐release carbamazepine monotherapy in patients with newly diagnosed epilepsy
por: Ben‐Menachem, Elinor, et al.
Publicado: (2019)

Safety and tolerability of short‐term infusions of intravenous lacosamide in pediatric patients with epilepsy: An open‐label, phase 2/3 trial
por: Farkas, Mark Kristof, et al.
Publicado: (2023)

Effects of lacosamide and carbamazepine on lipids in a randomized trial
por: Mintzer, Scott, et al.
Publicado: (2020)

Efficacy and safety of adjunctive lacosamide in the treatment of primary generalised tonic-clonic seizures: a double-blind, randomised, placebo-controlled trial
por: Vossler, David G, et al.
Publicado: (2020)

Analyses of seizure responses supportive of a novel trial design to assess efficacy of antiepileptic drugs in infants and young children with epilepsy: Post hoc analyses of pediatric levetiracetam and lacosamide trials
por: Johnson, Martin E., et al.
Publicado: (2021)

Time-to-Seizure Modeling of Lacosamide Used in Monotherapy in Patients with Newly Diagnosed Epilepsy
por: Lindauer, Andreas, et al.
Publicado: (2017)

Conversion to lacosamide monotherapy in the treatment of focal epilepsy: Results from a historical-controlled, multicenter, double-blind study
por: Wechsler, Robert T, et al.
Publicado: (2014)

Unmasking of myoclonus by lacosamide in generalized epilepsy
por: Birnbaum, Daniel, et al.
Publicado: (2016)

Safety and tolerability of lacosamide monotherapy in the elderly: A subgroup analysis from lacosamide trials in diabetic neuropathic pain
por: Bainbridge, Jacquelyn, et al.
Publicado: (2017)

Lacosamide monotherapy in clinical practice: A retrospective chart review
por: Villanueva, V., et al.
Publicado: (2018)

Safety of lacosamide in children with refractory partial epilepsy
por: Pasha, Ismail, et al.
Publicado: (2015)

The effect of lacosamide on psychiatric comorbidities in patients with epilepsy
por: Hasegawa, Naoya, et al.
Publicado: (2020)

The therapeutic effects of lacosamide on epilepsy-associated comorbidities
por: He, Zihua, et al.
Publicado: (2023)

Genomic and clinical predictors of lacosamide response in refractory epilepsies
por: Heavin, Sinéad B., et al.
Publicado: (2019)

Effectiveness and tolerability of lacosamide in children with drug resistant epilepsy
por: Driessen, J.T., et al.
Publicado: (2022)

Lacosamide may improve cognition in patients with focal epilepsy: EpiTrack to compare cognitive side effects of lacosamide and carbamazepine
por: Liguori, Claudio, et al.
Publicado: (2018)

Evaluation of Cardiovascular Concerns of Intravenous Lacosamide Therapy in Epilepsy Patients
por: Lu, Yan-Ting, et al.
Publicado: (2022)

Lacosamide as treatment for partial epilepsy: mechanisms of action, pharmacology, effects, and safety
por: Kellinghaus, Christoph
Publicado: (2009)

Ventricular tachycardia associated with lacosamide co-medication in drug-resistant epilepsy()
por: DeGiorgio, Andrew C., et al.
Publicado: (2012)

Lacosamide Precipitated Neutropenia in a Patient with Bipolar Disorder and Comorbid Epilepsy
por: Rao, Naren P., et al.
Publicado: (2018)

Effects of levetiracetam and lacosamide on therapeutic efficacy and neural function in patients with epilepsy
por: Liu, Airong, et al.
Publicado: (2020)

Clinical Efficacy and Safety of Lacosamide as an Adjunctive Treatment in Adults With Refractory Epilepsy
por: Hou, Liyan, et al.
Publicado: (2021)

A noninterventional study evaluating the effectiveness and safety of lacosamide added to monotherapy in patients with epilepsy with partial‐onset seizures in daily clinical practice: The VITOBA study
por: Runge, Uwe, et al.
Publicado: (2015)

Lacosamide as the first add-on therapy in adult patients with focal epilepsy: A multicenter real-world study
por: Liu, Wenyu, et al.
Publicado: (2023)

Clinical stabilisation with lacosamide of mood disorder comorbid with PTSD and fronto-temporal epilepsy
por: Cuomo, Ilaria, et al.
Publicado: (2017)

Safety and Tolerability of Lacosamide in Patients With Epilepsy: A Systematic Review and Meta-Analysis
por: Yang, Chunsong, et al.
Publicado: (2021)

Efficacy of Lacosamide in a Patient with Refractory Generalized Epilepsy Based on Video Electroencephalography
por: Yamada, Hidetada, et al.
Publicado: (2021)

Lacosamide as add-on treatment of focal symptomatic epilepsy in a patient with alcoholic liver cirrhosis
por: Romigi, A., et al.
Publicado: (2014)

Plasma lacosamide monitoring in children with epilepsy: Focus on reference therapeutic range and influencing factors
por: Li, Yue, et al.
Publicado: (2022)

Effectiveness and safety of Lacosamide therapy for children with focal epilepsy: a real world study
por: Yang, Chunsong, et al.
Publicado: (2023)

Equipotency of lacosamide to levetiracetam in new onset focal epilepsy: A randomized controlled trial
por: Jaiswal, Binaya Kumar, et al.
Publicado: (2023)

Lacosamide in Pediatric Status Epilepticus
por: Piantino, Juan A.
Publicado: (2017)

Lacosamide: Inefficacy: case report
Publicado: (2021)

Lacosamide poisoning improved by hemodialysis
por: Takahashi, Hiroki, et al.
Publicado: (2022)

A Clinical-EEG Study of Sleepiness and Psychological Symptoms in Pharmacoresistant Epilepsy Patients Treated with Lacosamide
por: Giorgi, Filippo S., et al.
Publicado: (2013)

Impact of ABCB1 Polymorphisms on Lacosamide Serum Concentrations in Uygur Pediatric Patients With Epilepsy in China
por: Zhao, Ting, et al.
Publicado: (2022)

Lacosamide on background eeg activity in brain tumor‐related epilepsy patients: A case series study
por: Maschio, Marta, et al.
Publicado: (2018)

A clinical efficacy experience of Lacosamide on sleep quality in patients with Nocturnal Frontal Lobe Epilepsy (NFLE)
por: Marilena, Mangiardi, et al.
Publicado: (2018)

Efficacy of Lacosamide Add-on Therapy on Refractory Focal Epilepsies in Children and Adolescents: An Open-Label Clinical Trial
por: Mohammadi, Tayebeh, et al.
Publicado: (2023)

Profile of lacosamide and its role in the long-term treatment of epilepsy: a perspective from the updated NICE guideline
por: Nunes, Vanessa Delgado, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_3tbo224rj9fdh62nik6hugm9eb